Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction

The corneal endothelium maintains corneal transparency; consequently, its dysfunction causes severe vision loss. Tissue engineering-based therapy, as an alternative to conventional donor corneal transplantation, is anticipated to provide a less invasive and more effective therapeutic modality. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Naoki, Sakamoto, Yuji, Fujii, Keita, Kitano, Junji, Nakano, Shinichiro, Tsujimoto, Yuki, Nakamura, Shin-ichiro, Ueno, Morio, Hagiya, Michio, Hamuro, Junji, Matsuyama, Akifumi, Suzuki, Shingo, Shiina, Takashi, Kinoshita, Shigeru, Koizumi, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870691/
https://www.ncbi.nlm.nih.gov/pubmed/27189516
http://dx.doi.org/10.1038/srep26113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870691/
https://www.ncbi.nlm.nih.gov/pubmed/27189516
http://dx.doi.org/10.1038/srep26113

Ejemplares similares